Literature DB >> 10051138

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia.

H Masuda1, M Goto, S Tamaoki, H Azuma.   

Abstract

1. We examined whether endogenous inhibitors of NO synthesis are involved in the augmentation of intimal hyperplasia in rabbits with hyperglycaemia induced by alloxan. 2. Four weeks after the endothelial denudation of carotid artery which had been performed 12 weeks after alloxan, the intimal hyperplasia was greatly augmented with hyperglycaemia. The degree of hyperplasia was assessed using three different parameters of histopathological findings as well as changes in luminal area and intima: media ratio. 3. There were positive and significant correlations between intima:media ratio, plasma glucose, and concentrations of N(G)-monomethyl-L-arginine (L-NMMA) and N(G), N(G)-dimethyl-L-arginine (ADMA) in endothelial cells, that is, the intima:media ratio became greater as plasma glucose and endothelial L-NMMA and ADMA were increased. Furthermore, endothelial L-NMMA and ADMA were increased in proportion to the increase in plasma glucose. 4. In contrast, there were inverse and significant correlations between cyclic GMP production by carotid artery strips with endothelium and plasma glucose, between cyclic GMP production and endothelial L-NMMA and ADMA, and between the intima:media ratio and cyclic GMP production. 5. Exogenously applied L-NMMA and ADMA inhibited cyclic GMP production in a concentration-dependent manner. IC50 values were determined to be 12.1 microM for the former and 26.2 microM for the latter. The cyclic GMP production was abolished after the deliberate removal of endothelium from the artery strips. 6. These results suggest that the augmentation of intimal hyperplasia with hyperglycaemia is closely related to increased accumulation of L-NMMA and ADMA with hyperglycaemia, which would result in an accelerated reduction in NO production/release by endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051138      PMCID: PMC1565802          DOI: 10.1038/sj.bjp.0702298

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

2.  Endothelium-dependent inhibition of platelet aggregation.

Authors:  H Azuma; M Ishikawa; S Sekizaki
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

Review 3.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

4.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

Review 5.  The discovery of nitric oxide as the endogenous nitrovasodilator.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Hypertension       Date:  1988-10       Impact factor: 10.190

6.  Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects.

Authors:  A R Christlieb; H U Janka; B Kraus; R E Gleason; E A Icasas-Cabral; L M Aiello; B V Cabral; A Solano
Journal:  Diabetes       Date:  1976-04       Impact factor: 9.461

7.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Authors:  U C Garg; A Hassid
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Atherosclerosis and myocardial ischemic lesions in alloxan-diabetic rabbits fed a low cholesterol diet.

Authors:  R A Miller; R B Wilson
Journal:  Arteriosclerosis       Date:  1984 Nov-Dec

9.  Vascular wall growth control: the role of the endothelium.

Authors:  S M Schwartz; C M Gajdusek; S C Selden
Journal:  Arteriosclerosis       Date:  1981 Mar-Apr

10.  Variations of susceptibility to alloxan induced diabetes in the rabbit.

Authors:  Z H Zhao; B Watschinger; C D Brown; M M Beyer; E A Friedman
Journal:  Horm Metab Res       Date:  1987-11       Impact factor: 2.936

View more
  10 in total

1.  Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemia.

Authors:  H Masuda; T Tsujii; T Okuno; K Kihara; M Goto; H Azuma
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes.

Authors:  William H Bestermann
Journal:  Cardiorenal Med       Date:  2011-10-04       Impact factor: 2.041

Review 3.  AGXT2: a promiscuous aminotransferase.

Authors:  Roman N Rodionov; Natalia Jarzebska; Norbert Weiss; Steven R Lentz
Journal:  Trends Pharmacol Sci       Date:  2014-10-13       Impact factor: 14.819

Review 4.  Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia.

Authors:  Michael J Osgood; Charles R Flynn; Padmini Komalavilas; Colleen Brophy
Journal:  Vascular       Date:  2012-10-26       Impact factor: 1.285

Review 5.  Cellular ADMA: regulation and action.

Authors:  Tom Teerlink; Zaiming Luo; Fredrik Palm; Christopher S Wilcox
Journal:  Pharmacol Res       Date:  2009-08-12       Impact factor: 7.658

6.  Plasma ADMA predicts restenosis of arteriovenous fistula.

Authors:  Chih-Cheng Wu; Szu-Chi Wen; Chung-Wei Yang; Shih-Yun Pu; Kuei-Chin Tsai; Jaw-Wen Chen
Journal:  J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 10.121

7.  Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease.

Authors:  Wiwat Chancharoenthana; Asada Leelahavanichkul; Sujittra Taratummarat; Jutamas Wongphom; Khajohn Tiranathanagul; Somchai Eiam-Ong
Journal:  PLoS One       Date:  2017-12-05       Impact factor: 3.240

Review 8.  Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside.

Authors:  Maciej Bladowski; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Anna Sawicz-Bladowska; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-08-28       Impact factor: 6.543

9.  Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis.

Authors:  Jessica H Chertow; Matthew S Alkaitis; Glenn Nardone; Allison K Ikeda; Aubrey J Cunnington; Joseph Okebe; Augustine O Ebonyi; Madi Njie; Simon Correa; Shamanthi Jayasooriya; Climent Casals-Pascual; Oliver Billker; David J Conway; Michael Walther; Hans Ackerman
Journal:  PLoS Pathog       Date:  2015-09-25       Impact factor: 6.823

10.  Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.

Authors:  Dmitry V Burdin; Alexey A Kolobov; Chad Brocker; Alexey A Soshnev; Nikolay Samusik; Anton V Demyanov; Silke Brilloff; Natalia Jarzebska; Jens Martens-Lobenhoffer; Maren Mieth; Renke Maas; Stefan R Bornstein; Stefanie M Bode-Böger; Frank Gonzalez; Norbert Weiss; Roman N Rodionov
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.